Lv4
540 积分 2023-05-06 加入
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
3天前
已完结
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
25天前
已完结
An in Vitro Assay Using Cultured Kupffer Cells Can Predict the Impact of Drug Conjugation on in Vivo Antibody Pharmacokinetics
25天前
已完结
Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology
26天前
已完结
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
30天前
已完结
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
30天前
已完结
An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody–Drug Conjugates
2个月前
已完结
Cathepsin B Cleavage of vcMMAE-Based Antibody–Drug Conjugate Is Not Drug Location or Monoclonal Antibody Carrier Specific
2个月前
已完结
Enzyme-Agnostic Lysosomal Screen Identifies New Legumain-Cleavable ADC Linkers
2个月前
已完结
A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin-cleavable ADC linkers
2个月前
已完结
皖公网安备34019202002308
